The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1264
July 2, 2007
View Complete Issue         Table of Contents 2019 
Resperate for Hypertension
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Resperate for Hypertension
July 2, 2007 (Issue: 1264)
The FDA has approved the marketing of Resperate (InterCure), a device that helps patients breathe slowly, as an adjunct for treatment of hypertension. The FDA does not require proof of effectiveness for approval of devices with minimal potential for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Resperate for Hypertension
Article code: 1264b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.